RAD51 and cancer: Others studies showed that TSA, vorinostat and abexinostat can repress BRCA1 (Breast Cancer 1) and RAD51 (Recombination Protein A) expressions [73,74] and thereby inhibit the homologous recombination and the non-homologous recombination end joining DDR mechanisms [70,74,75,76].